Dermoscopy in nail vitiligo
Part of Skin clinical trials.
This study uses dermoscopy (a special magnifying tool) to look at nails in people with vitiligo. It helps check if nail changes can give doctors more information about the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 50 years old.
- You have any type of vitiligo (focal, generalized, acrofacial, or segmental).
- You do not have an autoimmune disorder (like lupus, rheumatoid arthritis, or multiple sclerosis).
- You are not taking any long-term prescription medicine, including birth control pills.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This study looks at differences in the gut and skin microbiome (the germs living in and on the body) in people with vitiligo and in people without vitiligo. It aims to understand what might be linked to how vitiligo spreads over time.
This study uses a simple blood test to measure immune system signals (cytokines) that may indicate whether vitiligo is active or stable. The goal is to create a model that helps predict how the disease may progress.
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
This trial tests whether a new combination treatment (microneedling plus a non-steroidal ointment called crisaborole) can help repigment patches of vitiligo that have been stable for a while. It is for people with non-segmental vitiligo that is not spreading.
This study is creating a registry (a secure database) to track the health and treatment of children and adults with vitiligo in the UK. Joining helps researchers learn more about vitiligo and improve future care.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.